Document is current
Any future updates will be listed below
-
Authors
Heikal, Samia Yehia
Youssef, Ayda https://orcid.org/0000-0002-7558-2565
Nada, Ayman https://orcid.org/0000-0002-9296-9227
Madney, Youssef
Hassan, Ahmed E. https://orcid.org/0000-0003-1278-3834
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 4 March 2025
First Online: 29 March 2025
Declarations
:
: The current study had been approved by Institutional Review Board (IRB) of National Cancer Institute Cairo University and in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The approval number is 2212–501-35. The study number is RD2212-5081–029.
: Not applicable because of the retrospective type of study.
: AN is a PI on an industry funded clinical trial by Bayer HealthCare Pharmaceuticals. The remaining authors declare no conflict of interest.
